Chronic daily headache: Management and rehabilitation;Cefalea cronica quotidiana: Gestione e riabilitazione

Clinica Terapeutica

Volumn 157, Issue 2, 2006, Pages 153-157

  De Filippis, S ^a   Salvatori, E ^a   Coloprisco, G ^a   Martelletti, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic daily headache; Management; Medication overuse headache; Rehabilitation

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CAFFEINE; ERGOT ALKALOID; GLUTATHIONE REDUCTASE; GRANISETRON; HYDROCORTISONE; KETOROLAC; OPIATE; RANITIDINE; S ADENOSYLMETHIONINE; TIAPRIDE; TRYPTOPHAN; SEROTONIN AGONIST;

CHRONIC DAILY HEADACHE; CLINICAL FEATURE; DISABILITY; DISEASE CLASSIFICATION; DRUG DEPENDENCE; DRUG TOLERANCE; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; REHABILITATION; REVIEW; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; COMORBIDITY; DRUG COMBINATION; HEADACHE AND FACIAL PAIN; PATIENT EDUCATION; WITHDRAWAL SYNDROME;

ANALGESICS; COMORBIDITY; DRUG THERAPY, COMBINATION; HEADACHE DISORDERS; HUMANS; PATIENT EDUCATION; SEROTONIN AGONISTS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 33747448600     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Martelletti P, Leonardi M: The global impact of migraine. J Headache Pain 2003; 4(Suppl.1):1-2
2. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2d ed. Cephalalgia 2004; 24(Suppl 1):9-160
3. Castillo J, Munoz P, Guitera V, et al.: Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-6
4. Newman LC, Lipton RB. Solomon S, et al.: Daily headache in a population semple: results from the American Migraine Study. Headache 1994; 34:295
5. Smith R: Chronic Daily Headaches. Am Fam Physician 2004; 70:2299-306
6. Maizels M: The Patient with Daily Headaches. Am Family Physician 2004; 70:2299-306
7. Sandrini G, Proietti Cecchini A, Milanov I, et al.: Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett 2002; 317:135-8
8. Burstein R: Deconstructing migraine headache into peripheral and central sensitisation. Pain 2001; 89:107-10
9. Bahra A, Walsh M, Menon S, et al.: Does chronic daily headache arise de novo in association with regular use of analgesics. Headache 2003; 43:179-90
10. Tepper SJ: Analgesic overuse is a cause of chronic daily headache. Headache 2002; Â42:Â543-7
11. Dodick DW: Analgesic overuse is not a cause of chronic daily headache. Headache 2002; 42:547-54
12. Mathew NT, Stubits E, Nigan MP: Transformation of episodic migraine into daily headache: analysis of factor. Headache 1982; 22:66-8
13. Kudrow L: Paradoxical effects of frequent analgesic use: Adv Neurol 1982; 33:335-41
14. Rapoport AM, Weeks RE, Sheftell FD, et al.: Analgesic rebound headache: theoretical and pratical implications. Cephalalgia 1985; 5(supp3):448-9
15. Gladstone J, Eross E, Dodick D: Chronic daily headache: a rational approach to a challenging problem. Semin Neurol 2003; 23:265-76
16. Scher AI, Stewart W, Lieberman J, et al.: Prevalence of frequent headache in a population sample. Headache 1998; 38:497-506
17. Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000; 54:314-9
18. Lanteri-Minet M, Auray J.P, El Hasnaoui A, et al.: Prevalence and description of chronic daily headahe in the general population in France. Pain 2003; 102:143-9
19. Silberstein SD, Olesen J, Bousser MG, et al.: The International Classification of Headache Disorders, 2nd ed.-revision of criteria for 8.2 Medication-Overuse Headache. Cephalalgia 2005; 25, 460-5
20. Limmroth V, Katsarava Z, Pritsche G, et al.: Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59:1011-4
21. Calabresi P, Cupini LM: Medication overuse headache: similarities with drug addiction. Trends in Pharmacological Sciences 2005; 26, 2:62-8
22. Young WB: Medication overuse Headache. Curr Treat Options, Neurol 2001; 3:181-8
23. Limmroth V, Kazarawa S, Pritsche G, et al.: Features of medication overuse Headache following overuse of different acute headache drug. Neurology 2002; 59:1011-4
24. Diener HC, Dahöf CGH: Headache associated with chronic use of substances. In: Olesen J. Tfelt-Hasen P, Welch KMA, eds. The Headaches, 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 1999; 871-8
25. Saper JR, Hamel RL, Lake III AE: Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005; 25:545-6
26. Radat F, Creac'h C, Swendsen JD, et al.: Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005; 25:519-22
27. de Fiiippis S, Salvatori E, Coloprisco G, et al.: Headache and mood disorders, J Headache Pain 2005; 6:250-3
28. Atasoy HT, Atasoy N, Unal AE, et al.: Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain 2005; 9:285-91
29. Saper JR, Lake AE III: Borderline personality disorder and the chronic headache patient: review and management recommendation. Headache 2002; 42:663-74
30. Dowson AJ, Dodick DW, Limmroth V: Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 2005: 19:483-97
31. de Fiiippis S, Salvatori E, Cuomo I, et al.: Rehabiltation procedures for medication overuse headache (MOH). J Headache Pain 2004;5(Suppl.1), S25
32. Punay NC, Couch JR: Antidepressants in the treatment of migraine headach. Curr Pain Headache Rep 2003; 7:51-4
33. Krymchantowski AV, Silva MT, Barbosa JS, et al.: Amitriptilyne versus amitriptilyne combined with fluoxetine in the preventive treatment of trasformed migraine: a double-blind study. Headache 2002; 42:510-4
34. Freitag FG, Diamond S, Diamond ML, et al.: Divalproex in the long-term treatment of chronic daily headache, Headache 2001; 41:271-8
35. Brandes JL, Saper JR, Diamond M, et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004; 291:965-73
36. Silberstein SD, Neto W, Schmitt J, et al.: MIGR-001 Study Group, Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004; 61:490-5
37. Mathew NT: Antiepileptic drugs in migraine prevention. Headache 2002; 41(Suppl. 1), S18-S24
38. Silberstein SD, Goadsby PJ: Migraine: Preventive treatment. Cephalagia 2002; 22:491-512
39. Mathew NT, Kailasam J, Meadors L: Prophylaxis of migraine, transformed migraine, and cluster headache with Topiramate. Headache 2002; 42:796-803
40. Spira PJ, Baren RG: Gabapentin in the prophylaxis of Chronic Daily Headche: A randomized, placebo-controlled study, Neurology 2003; 61:1753-9
41. Coloprisco G, de Filippis S, Santi PG, et al.: Reduction in expenditures on analgesics during one year of treatment of Chronic tension Headache with BoNT-A. J Headache Pain 2003; 4:88-91
42. Silberstein SD, Peres MF, Hopkins MM, et al.: Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache 2002; 42:515-8
43. Saper JR, Lake AE III, Cantrell DT, et al.: Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome stud. Headache 2002; 42:470-82
44. Kaztarava Z, Limmroth V, Finke M, et al.: Rate and predictors for relapses in medication overuse headache: a one year prospective study. Neurology 2003; 60:1682-4
45. Kaztarava Z, Müssig M, Dzagnidze A, et al.: Medication overuse headache: rates and predictors for relapse in: a 4 year prospective study. Cephalalgia 2004; 25:12-5
46. Martelletti P: Pharmacoeconomics of migraine. J Headache Pain, 2002, 3:54
47. Iannazzo S, Cattaruzza MS, De Filippis S, et al.: Analgesic therapy for headache: consumption, appropriateness and costs. J Headache Pain 2003; 4(suppl. 1):S85-88